查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529572

药物安全检测市场：依临床试验阶段、依方法类型、依服务供应商类型、按地区

Pharmacovigilance Market, By Clinical Trial Phases, By Type of Method, By Type of Service Provider, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 175 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2024年全球药物安全检测市场规模为74.1亿美元，2031年将达128亿美元，2024年至2031年复合年增长率为8.1%。

报告范围 报告详情
基准年 2023年 2024年市场规模 74.1亿美元
实际资料 2019-2023 预测期 2024-2031
2024-2031 年预测期复合年增长率 8.10% 2031 年金额预测 128亿美元
图：2024 年按地区分類的药物安全检测市场占有率(%)
药物警戒市场-IMG1

近年来，全球药物安全检测市场经历了显着成长。药物安全检测被定义为与检测、评估、理解和预防副作用和其他药物相关问题相关的科学和活动。随着药物分子变得更加复杂，新的治疗方法不断推向市场，上市后有效监测药物安全性的需求也随之增加。强制进行药物安全监测的严格法律规范以及副作用的增加正在推动全球对药物安全检测服务的需求。此外，学名药市场的扩张以及临床试验向新兴地区的外包也进一步推动了药物安全检测市场的发展。

市场动态：

全球药物安全检测市场的推动因素包括药物副作用发生率的增加、药物核准的严格安全法规、对有效治疗方法的需求不断增加以及学名药市场的扩大。强制进行上市后监督的严格监管指南是推动药物安全检测服务需求的主要因素。此外，由于安全问题而导致的药品召回趋势不断增长，迫使药厂将药物安全检测业务委託给专业服务供应商。此外，已开发国家学名药市场的扩张为药物安全检测市场的参与企业提供了重大机会。然而，中小型製药企业的预算限制以及跨地区报告药品安全资料的复杂性给市场参与企业带来了挑战。

本研究的主要特点

  • 该报告详细分析了全球药物安全检测市场，并提供了以 2023 年为基准年的预测期（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球药物安全检测市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
  • 全球药物安全检测市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于全球药物安全检测市场分析的各种策略矩阵，将有助于相关人员做出决策。

目录

第一章 研究目的与前提

  • 研究目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • 一致的机会地图 (COM)

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球药物安全检测市场－冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章 全球药物安全检测市场，依临床试验阶段划分，2019-2031 年（十亿美元）

  • 介绍
  • 临床前研究
  • 临床试验一期
  • 临床试验二期
  • 临床试验III期
  • 上市后监督或第四阶段

第六章 全球药物安全检测市场，依方法类型，2019-2031（十亿美元）

  • 介绍
  • 自愿报告
  • 加强 ADR 报告
  • 目标报告
  • 群组心臟事件记录器
  • 电子病历监控

第七章 全球药物安全检测市场，依服务供应商类型，2019-2031（十亿美元）

  • 介绍
  • 公司内部
  • 合约外包

第八章全球药物安全检测市场，按地区，2019-2031（十亿美元）

  • 介绍
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东

第9章 竞争格局

  • 公司简介
    • Accenture
    • Cognizant Technology Solutions
    • Laboratory Corporation of America Holdings（LabCorp）
    • IBM Corporation
    • QuintilesIMS（IQVIA）
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation（UBC）
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Inc

第10章分析师建议

  • 上升和下降
  • 综合机会图

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI1047

The global pharmacovigilance market is estimated to be valued at USD 7.41 Bn in 2024 and is expected to reach USD 12.80 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 7.41 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 8.10% 2031 Value Projection: US$ 12.80 Bn
Figure. Pharmacovigilance Market Share (%), By Region 2024
Pharmacovigilance Market - IMG1

The global pharmacovigilance market has been witnessing significant growth in the recent years. Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding, prevention of adverse effects or any other drug-related problems. With the growing complexity of drug molecules and the introduction of novel therapies in the market, there is an increasing need to effectively monitor the safety of drugs post marketing. Stringent regulatory framework mandating drug safety monitoring along with increasing instances of adverse drug reactions is propelling the demand for pharmacovigilance services across the globe. Furthermore, the expanding generics market and outsourcing of clinical trials to emerging regions has further boosted the pharmacovigilance market.

Market Dynamics:

The global pharmacovigilance market is driven by the rising number of adverse drug reactions, stringent safety regulations for drug approval, increasing demand for efficacious therapies, and growing generics market. Stringent regulatory guidelines mandating post marketing surveillance is a key factor augmenting the demand for pharmacovigilance services. Furthermore, rising trend of drug recalls due to safety issues has compelled pharmaceutical companies to outsource their pharmacovigilance activities to specialized service providers. Moreover, increasing generics market in developed countries offer significant opportunities for the pharmacovigilance market players. However, budget constraints of small and midsize pharmaceutical companies and complexity of reporting drug safety data across regions pose challenges to market players.

Key Features of the Study:

  • This report provides in-depth analysis of the global pharmacovigilance market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pharmacovigilance market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, ArisGlobal, ICON plc., Capgemini, ITClinical, FMD K&L, and IQVIA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pharmacovigilance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharmacovigilance market

Detailed Segmentation-

  • By Clinical Trial Phases
    • Total Knee Replacement
    • Partial Knee Replacement
    • Kneecap Replacement
    • Revision Knee Replacement
  • By Type of Method
    • Spontaneous Reporting
    • Intensified ADR Reporting
    • Targeted Reporting
    • Cohort Event Monitoring
    • EHR Monitoring
  • By Type of Service Provider
    • In-House
    • Contract Outsourcing
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Accenture
    • Cognizant Technology Solutions
    • Laboratory Corporation of America Holdings (LabCorp)
    • IBM Corporation
    • QuintilesIMS (IQVIA)
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation (UBC)
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Incc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Clinical Trial Phases
    • Market Snapshot, By Type of Method
    • Market Snapshot, By Type of Service Provider
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Pharmacovigilance Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Pharmacovigilance Market, By Clinical Trial Phases, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Pre-clinical Studies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Clinical Trial Phase I
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Clinical Trial Phase II
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Clinical Trial Phase III
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Post Marketing Surveillance or Phase IV
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Pharmacovigilance Market, By Type of Method, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Spontaneous Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Intensified ADR Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Targeted Reporting
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Cohort Event Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • EHR Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Pharmacovigilance Market, By Type of Service Provider, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • In-House
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Contract Outsourcing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Pharmacovigilance Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Accenture
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cognizant Technology Solutions
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Laboratory Corporation of America Holdings (LabCorp)
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • IBM Corporation
    • QuintilesIMS (IQVIA)
    • ICON plc
    • Capgemini
    • ITClinical
    • TAKE Solutions Ltd
    • BioClinica
    • PAREXEL International Corporation
    • Wipro Ltd
    • FMD K&L
    • Linical Accelovance
    • United BioSource Corporation (UBC)
    • PRA Health Sciences
    • ArisGlobal
    • Ennov Solutions Inc

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact